| 1 (36) | Samsung Corp * | MUL |  |
| 2 (99) | Janssen | MUL | |
| 3 (100) | Johnson & Johnson * | MUL | |
| 4 (159) | Novo Nordisk * | MUL | |
| 5 (162) | Pfizer * | MUL | |
| 6 (163) | Eusko Jaurlaritza * | MUL |  |
| 7 (174) | Gilead Sciences * | MUL | |
| 8 (199) | Pasteur Network * | MUL |  |
| 9 (204) | Takeda Pharmaceuticals International Inc * | MUL | |
| 10 (357) | Eli Lilly * | MUL | |
| 11 (511) | AbbVie * | MUL | |
| 12 (513) | Generalitat Valenciana * | MUL | |
| 13 (528) | F Hoffmann-La Roche * | MUL | |
| 14 (692) | Junta de Andalucia * | MUL | |
| 15 (768) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 16 (906) | Grupo Hospitalario Quironsalud * | MUL | |
| 17 (1162) | Manipal Global Education Group * | MUL | |
| 18 (1201) | IVIRMA Global * | MUL | |
| 19 (1215) | Siemens * | MUL | |
| 20 (1321) | General Electric Company * | MUL | |
| 21 (1405) | IQVIA Inc * | MUL | |
| 22 (1447) | GE Healthcare | MUL | |
|
